[go: up one dir, main page]

SG145723A1 - Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine - Google Patents

Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine

Info

Publication number
SG145723A1
SG145723A1 SG200805893-5A SG2008058935A SG145723A1 SG 145723 A1 SG145723 A1 SG 145723A1 SG 2008058935 A SG2008058935 A SG 2008058935A SG 145723 A1 SG145723 A1 SG 145723A1
Authority
SG
Singapore
Prior art keywords
phenylindan
dimethylpiperazine
chloro
trans
salts
Prior art date
Application number
SG200805893-5A
Inventor
Benny Bang-Andersen
Klaus Peter Bigesi
Klaus Gjervig Jensen
Henrik Svane
Allan Carsten Dahl
Mark Howells
Lars Ole Lyngsi
Tomas Mow
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG145723A1 publication Critical patent/SG145723A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18—Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Trans-1(6-Chloro-3-Phenylindan-l.-Y1)-3,3-Dimethylpiperazine A compound 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-2,2-dimethylpiperazine and salts thereof, pharmaceutical compositions comprising the compound and salts, and medical use thereof, including for treatment of schizophrenia and other psychotic disorders.
SG200805893-5A 2003-08-18 2004-08-18 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine SG145723A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301180 2003-08-18
DKPA200301305 2003-09-11

Publications (1)

Publication Number Publication Date
SG145723A1 true SG145723A1 (en) 2008-09-29

Family

ID=58707237

Family Applications (2)

Application Number Title Priority Date Filing Date
SG200805893-5A SG145723A1 (en) 2003-08-18 2004-08-18 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
SG200808521-9A SG148183A1 (en) 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-(1r,3s)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG200808521-9A SG148183A1 (en) 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-(1r,3s)-6-chloro-3-phenylindan-1-yl)- 1,2,2-trimethylpiperazine and the use as a medicament

Country Status (15)

Country Link
KR (2) KR101227789B1 (en)
CN (1) CN101935305B (en)
AR (2) AR045278A1 (en)
AT (1) ATE552247T1 (en)
DK (1) DK1658277T3 (en)
EA (2) EA014641B1 (en)
ES (1) ES2383369T3 (en)
IS (1) IS8264A (en)
ME (1) MEP2408A (en)
MY (2) MY154535A (en)
PT (1) PT1658277E (en)
RS (3) RS53369B (en)
SG (2) SG145723A1 (en)
SI (1) SI1658277T1 (en)
TW (2) TWI388550B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI453198B (en) * 2005-02-16 2014-09-21 Lundbeck & Co As H Process for making the trans-1-( (1r , 3s)- 6-chloro - 3 -phenylindan-1- yl ) - 3 , 3 - dimethylpiperazine and salts thereof and for making 4 -((1r , 3s )-6- chloro- 3- phenylindan -1- yl )-1, 2 , 2 -trimethylpiperazine and salts thereof
ME02513B (en) 2011-06-20 2017-02-20 H Lundbeck As DEUTERATED 1-PIPERAZINE-3-PHENYL-INDANE FOR THE TREATMENT OF SCHIZOPHRENIA
CA3136599A1 (en) 2019-04-11 2020-10-15 Mei Pharma, Inc. Voruciclib poly morphs and methods of making and using thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196284A (en) * 1980-02-29 1983-12-16 Kefalas As 1-piperazino-3-phenylindane derivatives:pharmaceutical compositions
DK55192D0 (en) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindene derivatives

Also Published As

Publication number Publication date
KR101227789B1 (en) 2013-01-30
MEP2408A (en) 2010-02-10
TWI388550B (en) 2013-03-11
MY149089A (en) 2013-07-15
DK1658277T3 (en) 2012-06-18
EA200600443A1 (en) 2006-08-25
ATE552247T1 (en) 2012-04-15
TW200519098A (en) 2005-06-16
AR045278A1 (en) 2005-10-19
RS20060083A (en) 2008-08-07
CN101935305A (en) 2011-01-05
KR20060066094A (en) 2006-06-15
PT1658277E (en) 2012-05-25
RS20060121A (en) 2008-09-29
KR20060066104A (en) 2006-06-15
IS8264A (en) 2006-01-26
MY154535A (en) 2015-06-30
RS53369B (en) 2014-10-31
TW201111351A (en) 2011-04-01
ES2383369T3 (en) 2012-06-20
SI1658277T1 (en) 2012-10-30
HK1096089A1 (en) 2007-05-25
SG148183A1 (en) 2008-12-31
EA200600441A1 (en) 2006-08-25
EA014641B1 (en) 2010-12-30
AR045279A1 (en) 2005-10-19
CN101935305B (en) 2013-04-10
HK1152699A1 (en) 2012-03-09
TWI403505B (en) 2013-08-01

Similar Documents

Publication Publication Date Title
NO20061153L (en) Trans-1- (6-chloro-3-phenylindan-1-yl) -3,3-dimethylpiperazine
NO20090229L (en) 1- [2- (2,4-Dimethylphenylsulfanyl-phenyl] -piperazine as a compound with combined serotonin reuptake, 5-HT3, and 5HT1A activity for the treatment of cognitive pain
WO2003004480A3 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
NO20056130L (en) New substituted 3-sulfur indoles
NO20070855L (en) Arylidenides for the treatment of estrogen-related receptor-alpha-mediated diseases.
CY1112646T1 (en) THERAPEUTIC USES OF COMPOUNDS WHICH HAVE COMBINED ACTIVITY SERT, 5-HT3 AND 5-HT1A
AU2003269364A1 (en) Use of piperazine derivatives as ccr1 antagonists
CY1111857T1 (en) CRYSTAL BASE OF TRANS-1 - ((1R, 3S) -6-HULPO-3-FINYLINDAN-1-YLO) -3,3-DIMETHYLPIPERAZINE
WO2002092072A3 (en) Drugs for the treatment of the alzheimer disease
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
AU2003260882A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
SG145723A1 (en) Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
SE0401968D0 (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
WO2006064228A3 (en) Thiazolopyramidine compounds for the modulation of chemokine receptor activity
UA89617C2 (en) Succinate and malonate salt of trans 4-(1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and use thereof as a medicament
AU2003294952A1 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
SE0301442D0 (en) Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
WO2005113526A3 (en) Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
SE0202287D0 (en) New compounds
UA96570C2 (en) Histamine h3 -receptor ligands and therapeutic use thereof
MXPA04000581A (en) 2 -(aminomethyl) -tetrahydro -9-oxa -1, 3-diaza -cyclopenta [a] naphthalenyl derivatives with antipsychotic activity.
EP1541553A4 (en) Novel indoline compound and medicinal use thereof
ITTO20040343A1 (en) USE OF NEBOGLAMINE (CR2249) AS A NEUROPSYCHOTIC AND NEUROPROTECTIVE
HK1086754A (en) Use of 10-hydroxy-10, 11-dihydrocarbamazepine derivatives for the treatment of affective disorders
UA101341C2 (en) Normal;heading 1;heading 2;heading 3;THERAPEUTIC USES OF COMPOUNDS HAVING COMBINED SERT, 5-HT3 AND 5-HT1A ACTIVITY